Clincosm LogoSign in Get a demo

Dry Eye Disease

Showing NaN - NaN of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Disease Trial in Andover (Reproxalap Ophthalmic Solution (0.25%), Placebo Comparator)

Completed
  • Dry Eye Disease
  • Reproxalap Ophthalmic Solution (0.25%)
  • Placebo Comparator
  • Andover, Massachusetts
    Andover Eye Associates
Jan 24, 2023

Dry Eye Disease Trial in Andover, Shelby, Memphis (SI-614, Vehicle)

Recruiting
  • Dry Eye Disease
  • Newport Beach, California
  • +6 more
Jan 22, 2023

Dry Eye Disease Trial in United States (AR-15512 Ophthalmic Solution, Vehicle)

Recruiting
  • Dry Eye Disease
  • Newport Beach, California
  • +10 more
Jan 17, 2023

Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)

Completed
Has Results
  • Dry Eye Disease
  • CyclASol topical ocular, eye drops
  • Vehicle topical ocular, eye drops
  • Newport Beach, California
  • +8 more
Dec 21, 2022

Dry Eye Disease Trial in Andover (glycerin 0.7%/PEG 400 0.3%, polyethylene glycol 400 0.4%/propylene glycol 0.3%)

Enrolling by invitation
  • Dry Eye Disease
  • glycerin 0.7%/PEG 400 0.3%
  • polyethylene glycol 400 0.4%/propylene glycol 0.3%
  • Andover, Massachusetts
    Andover Research Eye Institute
Dec 20, 2022

Dry Eye Disease Trial in Andover, Raynham, Memphis (ST-100 Ophthalmic Solution, Placebo Ophthalmic Solution)

Completed
  • Dry Eye Disease
  • ST-100 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Andover, Massachusetts
  • +2 more
Feb 22, 2022

Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)

Completed
  • Dry Eye Disease
  • CyclASol topical ocular, eye drops
  • Vehicle topical ocular, eye drops
  • Phoenix, Arizona
  • +26 more
Jan 5, 2022

Dry Eye Disease Trial in Louisville, Andover, Nashville (0.2 % hemigalactarate (0.11% free base) 0.2 % OC-02 Low Dose (1.1

Completed
Has Results
  • Dry Eye Disease
  • 0.2 % hemigalactarate (0.11% free base) 0.2 % OC-02 Low Dose (1.1 mg/mL)
  • +3 more
  • Louisville, Kentucky
  • +2 more
Nov 16, 2021

Dry Eye Disease Trial in Newport Beach, Indianapolis, Andover (OC-01 (varenicline) nasal spray, Placebo (vehicle) nasal spray)

Completed
Has Results
  • Dry Eye Disease
  • OC-01 (varenicline) nasal spray
  • Placebo (vehicle) nasal spray
  • Newport Beach, California
  • +2 more
Oct 21, 2021

Keratoconjunctivitis Sicca, Dry Eye Disease Trial in United States (Lifitegrast, Placebo)

Completed
Has Results
  • Keratoconjunctivitis Sicca
  • Dry Eye Disease
  • Waterbury, Connecticut
  • +12 more
Jun 2, 2021

Dry Eye Disease Trial in United States (K-161, Placebo (Vehicle))

Completed
  • Dry Eye Disease
  • Newport Beach, California
  • +3 more
Mar 23, 2021

Dry Eye Disease Trial in United States (PL9643 Ophthalmic Solution, Placebo Ophthalmic Solution)

Completed
  • Dry Eye Disease
  • PL9643 Ophthalmic Solution
  • Placebo Ophthalmic Solution
  • Andover, Massachusetts
  • +3 more
Nov 12, 2020